From Preclinical Data to IND Filing: BioBoston’s Strategic Approach to Drug Development Success
October 27, 2025
The journey from preclinical research to an Investigational New Drug (IND) filing marks a pivotal phase in drug development. For biotech startups and pharmaceutical innovators,